Annual Report

Overview

The report presents the company's 2024 ESG performance across its pharmaceutical and fitness businesses, covering environmental protection, resource use, climate change, employment, health and safety, supply chain, product responsibility, anti-corruption and community investment. It describes a Board-led ESG governance structure and a formal materiality assessment based on stakeholder questionnaires and management review. The company reports 714 employees and zero work-related fatalities for 2024, while disclosing segment-level electricity, water and waste metrics.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Publication date: 28 March 2025
Language: English, Chinese
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services